Evaluation of the pharmacodynamics and pharmacokinetics of the PARP inhibitor olaparib: A Phase i multicentre trial in patients scheduled for elective breast cancer surgery

Nigel Bundred, Janis Gardovskis, Janusz Jaskiewicz, Janis Eglitis, Viktor Paramonov, Peter McCormack, Helen Swaisland, Maria Cavallin, Tony Parry, James Carmichael, J. Michael Dixon

Research output: Contribution to journalArticlepeer-review

68 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Evaluation of the pharmacodynamics and pharmacokinetics of the PARP inhibitor olaparib: A Phase i multicentre trial in patients scheduled for elective breast cancer surgery'. Together they form a unique fingerprint.

Medicine & Life Sciences